0001410442-24-000005.txt : 20240903 0001410442-24-000005.hdr.sgml : 20240903 20240903180536 ACCESSION NUMBER: 0001410442-24-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240903 FILED AS OF DATE: 20240903 DATE AS OF CHANGE: 20240903 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jain Vivek CENTRAL INDEX KEY: 0001410442 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34634 FILM NUMBER: 241275342 MAIL ADDRESS: STREET 1: ICU MEDICAL, INC. STREET 2: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92673 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ICU MEDICAL INC/DE CENTRAL INDEX KEY: 0000883984 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 330022692 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 BUSINESS PHONE: 949-366-2183 MAIL ADDRESS: STREET 1: 951 CALLE AMANECER CITY: SAN CLEMENTE STATE: CA ZIP: 92763-6212 4 1 edgardoc.xml PRIMARY DOCUMENT X0508 4 2024-09-03 0 0000883984 ICU MEDICAL INC/DE ICUI 0001410442 Jain Vivek 951 CALLE AMANECER SAN CLEMENTE CA 92673 1 1 0 0 Chairman and CEO 1 Common Stock 2024-09-03 4 M 0 3755 88.76 A 108348 D Common Stock 2024-09-03 4 S 0 3755 162.694 D 104593 D Common Stock 2024-09-03 4 M 0 4440 88.76 A 109033 D Common Stock 2024-09-03 4 S 0 4440 163.587 D 104593 D Common Stock 2024-09-03 4 M 0 3805 88.76 A 108398 D Common Stock 2024-09-03 4 S 0 3805 164.0731 D 104593 D Common Stock 88698 I by Trust Non-Qualified Stock Option (right to buy) 88.76 2024-09-03 4 M 0 3755 88.76 D 2018-02-11 2025-02-11 Common Stock 3755 45618 D Non-Qualified Stock Option (right to buy) 88.76 2024-09-03 4 M 0 4440 88.76 D 2018-02-11 2025-02-11 Common Stock 4440 41178 D Non-Qualified Stock Option (right to buy) 88.76 2024-09-03 4 M 0 3805 88.76 D 2018-02-11 2025-02-11 Common Stock 3805 37373 D The option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $161.98 to $162.94, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $162.99 to $163.96, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $164.00 to $164.5, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. By: Paula Darbyshire, Attorney-in-fact For: Vivek Jain 2024-09-03